-
-
-
-
-
-
-
๐๐จ๐จ ๐๐ฅ๐ ๐๐จ๐ซ ๐๐ก๐ข๐ฌ, ๐๐จ๐จ ๐๐จ๐ฎ๐ง๐ ๐๐จ๐ซ ๐๐ก๐๐ญ!: ๐๐จ๐ฎ๐ซ ๐๐ฎ๐ซ๐ฏ๐ข๐ฏ๐๐ฅ ๐๐ฎ๐ข๐๐ ๐๐จ๐ซ ๐ญ๐ก๐ ๐๐ข๐๐๐ฅ๐-๐๐๐ก๐จ๐จ๐ฅ ๐๐๐๐ซ๐ฌ
69.000VND69.000VND× -
๐๐ก๐ ๐๐ซ๐๐ ๐จ๐ง๐๐ญ ๐๐ซ๐จ๐ฉ๐ก๐๐๐ฒ
59.000VND59.000VND× -
-
-
-
๐๐๐๐จ๐ฆ๐ข๐ง๐ ๐๐จ๐ง๐ฏ๐๐ซ๐ฌ๐๐ง๐ญ ๐ฐ๐ข๐ญ๐ก ๐ญ๐ก๐ ๐๐ฆ๐๐ซ๐ ๐ข๐ง๐ ๐๐ก๐ฎ๐ซ๐๐ก: ๐๐ง๐๐๐ซ๐ฌ๐ญ๐๐ง๐๐ข๐ง๐ ๐ ๐๐จ๐ฏ๐๐ฆ๐๐ง๐ญ ๐๐ง๐ ๐๐ญ๐ฌ ๐๐ฆ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง๐ฌ
79.000VND79.000VND× -
-
๐๐ก๐ ๐๐ข๐ฅ๐ฅ๐๐ซ๐ฌ ๐จ๐ ๐๐๐ซ๐๐ฎ๐ฅ๐๐ฌ
99.000VND99.000VND× -
-
-
-
-
-
-
๐๐ฒ๐๐ฅ๐จ๐ข๐ ๐๐๐ฅ๐ฅ๐ฌ
Author: Spencer A. Douglas, 154 pages, hardcover.
In this book the authors present current research in the study of the biology and regulation, role in cancer progression and potential implications for therapy of myeloid cells. Topics discussed include the differentiation signalling induced by retinoic acid and vitamin D3; proline rich homeodomain (Prh/Hhex) protein in the control of haematopoiesis and myeloid cell proliferation and its potential as a therapeutic target in myeloid leukaemias and other cancers; apoptosis, cell cycle and epigenetic processes deregulation in myeloproliferative neoplasms; use of animal models to evaluate myeloid cell dysfunction in cancer; use of animal models to evaluate myeloid cell dysfunction in cancer; and the biology of myeloid cells mediating tumour recurrence after radiotherapy.
99.000VND











